phenylalanine has been researched along with thromboplastin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, J; Guha, A; Hasselbacher, CA; Kohanski, RA; Lam, W; Lin, TC; Polikarpov, I; Rusinova, E; Rusinova, R; Waxman, E | 1 |
Petrovan, RJ; Ruf, W | 1 |
Abdel-Meguid, SS; Babine, RE; Jin, L; Navaneetham, D; Pandey, P; Strickler, JE; Walsh, PN | 1 |
3 other study(ies) available for phenylalanine and thromboplastin
Article | Year |
---|---|
Environments of the four tryptophans in the extracellular domain of human tissue factor: comparison of results from absorption and fluorescence difference spectra of tryptophan replacement mutants with the crystal structure of the wild-type protein.
Topics: Base Sequence; Circular Dichroism; Drug Stability; Factor VIIa; Humans; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Phenylalanine; Point Mutation; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Restriction Mapping; Spectrometry, Fluorescence; Thromboplastin; Tryptophan; Tyrosine | 1995 |
Role of residue Phe225 in the cofactor-mediated, allosteric regulation of the serine protease coagulation factor VIIa.
Topics: Allosteric Regulation; Animals; Catalysis; CHO Cells; Cricetinae; Enzyme Stability; Factor VIIa; Humans; Hydrolysis; Mutagenesis, Site-Directed; Peptide Fragments; Phenylalanine; Proline; Protein Binding; Serine Endopeptidases; Surface Plasmon Resonance; Thromboplastin | 2000 |
Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2.
Topics: Alanine; Alzheimer Disease; Arginine; Binding Sites; Carrier Proteins; Catalytic Domain; Crystallography, X-Ray; Disulfides; DNA Mutational Analysis; Dose-Response Relationship, Drug; Factor XIa; Humans; Inhibitory Concentration 50; Kinetics; Lysine; Models, Molecular; Models, Statistical; Mutation; Partial Thromboplastin Time; Phenylalanine; Plasmids; Point Mutation; Proline; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins; Serine; Serine Proteinase Inhibitors; Structure-Activity Relationship; Thromboplastin; Time Factors; Vesicular Transport Proteins | 2005 |